Seres Therapeutics logo
Seres Therapeutics MCRB
$ 0.77 5.26%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Seres Therapeutics Financial Ratios 2011-2024 | MCRB

Annual Financial Ratios Seres Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.2 -2.3 -11.2 -17.0 -2.7 -2.5 -4.7 -4.1 -11.6 - - - -

P/S

1.1 79.8 5.1 45.7 5.5 8.8 13.1 17.2 - - - - -

EPS

-0.9 -2.3 -0.7 -1.1 -1.2 -2.4 -2.2 -2.3 -2.3 -2.7 -1.1 - -

EV (Enterprise Value)

412 M 743 M 769 M 1.57 B 305 M 332 M 514 M 460 M 571 M 29.9 M 11.6 M - -

EBITDA per Share

-0.79 -2.22 -0.64 -1.02 -1.11 -2.27 -2.08 -2.22 -2.3 - - - -

EV/EBITDA

-13.3 -23.2 -2.4 -1.8 -4.6 -3.6 -10.3 - - - -

PEG

-0.07 -0.07 0.6 1.42 -0.05 0.25 -1.21 -3.18 0.05 - - - -

P/B

-3.1 52.7 5.6 8.7 -3.9 -5.2 6.9 2.8 3.1 - - - -

P/CF

-1.2 -2.5 109.7 -16.2 -2.4 -3.9 -5.3 16.7 -14.0 - - - -

ROE %

253.53 -2319.92 -49.87 -51.00 145.43 205.94 -147.25 -69.05 -26.67 - - - -

ROA %

-31.71 -71.72 -18.48 -25.99 -53.06 -82.13 -47.16 -33.59 -25.26 - - - -

ROCE %

240.73 -2285.91 -49.04 -50.43 -81.42 -127.86 -57.88 -38.33 -26.63 - - - -

Current Ratio

0.9 1.0 1.6 2.0 2.2 2.2 4.9 6.5 19.0 - - - -

DSO

- - - 9.8 18.9 - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - 9.8 - - - - - - - - -

Cash Conversion Cycle

- - - 9.8 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Seres Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.58 -0.22 -0.27 - -0.37 0.36 -0.57 - -0.49 -0.7 -0.61 - 0.74 -0.53 -0.39 - -0.36 -0.28 -0.28 -0.27 -0.23 -0.24 -0.59 -0.52 -0.54 -0.68 -0.69 -0.72 -0.17 -0.69 -0.63 -0.63 -0.46 -0.7 -0.5 -0.5 -0.38 -1.45 -1.15 -1.24 -0.68 -0.45 -0.29 - - - - - - - - - - - -

EBITDA per Share

-0.18 -0.2 -0.26 - -0.33 0.4 -0.55 - -0.47 -0.67 -0.59 - 0.76 -0.51 -0.37 - -0.34 -0.26 -0.25 -0.27 -0.22 -0.2 -0.55 -0.53 -0.5 -0.64 -0.65 -0.73 -0.13 -0.66 -0.6 -0.64 -0.44 -0.69 -0.5 -0.51 -0.37 -1.41 -0.93 -1.05 -0.52 -0.38 - - - - - - - - - - - - -

ROE %

792.52 737.80 905.90 670.97 582.19 176.97 -309.63 -439.47 -400.65 -273.06 -40.13 -33.68 -51.01 -107.15 -71.19 -40.56 -1.70 49.58 83.70 145.43 150.88 162.61 198.18 205.94 113.93 56.82 -47.17 -147.25 -118.61 -121.27 -96.16 -69.05 -59.55 -52.58 -37.65 -26.67 13.51 36.20 52.33 56.21 25.59 10.02 - - - - - - - - - - - - -

ROA %

14.68 -48.01 -26.33 -27.90 -47.14 -53.37 -82.52 -54.64 -37.43 16.73 -1.20 -12.31 -21.14 -47.18 -35.30 -20.67 -34.85 -38.41 -40.49 -53.06 -56.56 -62.39 -77.33 -82.13 -79.74 -65.18 -56.89 -47.16 -41.15 -44.35 -39.80 -33.59 -33.37 -33.26 -28.81 -25.26 -23.18 -19.98 -16.47 -12.80 -5.83 -2.28 - - - - - - - - - - - - -

ROCE %

275.13 691.91 874.91 661.23 573.78 191.50 -302.13 -430.96 -392.03 -265.65 -38.65 -33.29 -50.46 -106.55 -70.67 -40.19 -0.47 52.25 86.66 148.74 154.13 164.80 200.71 208.73 114.57 56.29 -49.09 -150.57 -120.89 -123.23 -97.63 -70.00 -60.26 -52.96 -37.75 -26.71 9.92 30.40 46.21 50.19 23.19 9.80 - - - - - - - - - - - - -

Current Ratio

1.1 0.8 0.8 0.9 1.0 1.1 0.8 1.0 1.3 - 1.3 1.6 1.8 1.6 1.9 2.0 2.0 2.0 2.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.5 1.5 1.5 1.5 1.9 1.9 1.9 1.9 18.9 18.9 18.9 18.9 14.7 14.7 14.7 - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - 0.9 33.4 95.7 - 604.5 141.7 62.2 - 23.2 13.0 11.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - 0.9 33.4 95.7 - 604.5 141.7 62.2 - 23.2 13.0 11.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - 0.9 33.4 95.7 - 604.5 141.7 62.2 - 23.2 13.0 11.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency